A novel approach to assess Lung Health

Functional Respiratory Imaging (FRI) is a imaging technology which enhances drug development and patient care by providing patient-specific parameters

A novel approach to assess Lung Health

Functional Respiratory Imaging (FRI) is a imaging technology which enhances drug development and patient care by providing patient-specific parameters

Patient-specific parameters

  • 3D visualization and quantification of patient’s airway and lung geometry on a regional, often lobar, level
  • Deposition characteristics of inhaled compounds

Patient-specific parameters

  • 3D visualization and quantification of patient’s airway and lung geometry on a regional, often lobar, level
  • Deposition characteristics of inhaled compounds

FRI benefits

Use in Clinical Trials

FRI reduces the cost and time required for screening most promising new respiratory drugs in early clinical phase

Use in Clinical Practice

FRI is sensitive and identifies more quickly inefficient therapies, improving patient care

FRI benefits

Use in Clinical Trials

FRI reduces the cost and time required for screening most promising new respiratory drugs in early clinical phase

Use in Clinical Practice

FRI is sensitive and identifies more quickly inefficient therapies, improving patient care

FLUIDDA’s technique and insights to the subject were outstanding. We were delighted with the science and collaboration we had with FLUIDDA.

Mark Milton – Edwards Global Dir. Respiratory, TEVA

FLUIDDA’s technology is an important tool which helps bridge data from in vitro and in vivo studies.

Dr. Paul M. Dorinsky – Head Global Respiratory Clinical Development, Cipla

FLUIDDA’s technique and insights to the subject were outstanding. We were delighted with the science and collaboration we had with FLUIDDA.

Mark Milton – Edwards Global Dir. Respiratory, TEVA

FLUIDDA’s technology is an important tool which helps bridge data from in vitro and in vivo studies.

Dr. Paul M. Dorinsky – Head Global Respiratory Clinical Development, Cipla

This study will be presented at ERS 2019 at a thematic poster session on Monday September 30 between 12.50 pm
Read More
This study will be presented at ERS 2019 at a thematic poster session on Sunday September 29 between 12.50 pm
Read More
From  September 28 until October 2, Fluidda will exhibit at the annual conference of the European Respiratory Society in Madrid, Spain.
Read More
FLUIDDA is the leading company in the field of Functional Respiratory imaging (FRI). FLUIDDA develops respiratory solutions to detect lung
Read More